For help on how to get the results you want, see our search tips.
1720 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Orphan designations Remove Orphan designations filter
Orphan designation status
Positive Remove Positive filter
-
List item
Orphan designation: Palovarotene for: Treatment of multiple osteochondromas (updated)
Date of first decision: 27/06/2018, Positive, Last updated: 17/05/2021 -
List item
Orphan designation: Ivacaftor, N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide, tezacaftor for: Treatment of cystic fibrosis (updated)
Date of first decision: 14/12/2018, Positive, Last updated: 06/05/2021 -
List item
Orphan designation: Teicoplanin for: Treatment of cystic fibrosis (updated)
Date of first decision: 23/08/2017, Positive, Last updated: 06/05/2021 -
List item
Orphan designation: Anti-neonatal Fc receptor human monoclonal antibody for: Prevention of haemolytic disease of the foetus and newborn (updated)
Date of first decision: 17/10/2019, Positive, Last updated: 05/05/2021 -
List item
Orphan designation: Risdiplam for: Treatment of spinal muscular atrophy (updated)
Date of first decision: 26/02/2019, Positive, Last updated: 04/05/2021 -
List item
Orphan designation: pemigatinib for: Treatment of biliary tract cancer (updated)
Date of first decision: 24/08/2018, Positive, Last updated: 04/05/2021 -
List item
Orphan designation: L-cystine bis(N-methylpiperazide) for: Treatment of cystinuria (updated)
Date of first decision: 27/06/2018, Positive, Last updated: 30/04/2021 -
List item
Orphan designation: Mexiletine hydrochloride for: Treatment of non-dystrophic myotonia (updated)
Date of first decision: 07/06/2013, Positive, Last updated: 30/04/2021 -
List item
Orphan designation: lonapegsomatropin for: Treatment of growth hormone deficiency (updated)
Date of first decision: 17/10/2019, Positive, Last updated: 29/04/2021 -
List item
Orphan designation: 1,2:5,6-Dianhydrogalactitol for: Treatment of glioma (updated)
Date of first decision: 24/01/2013, Positive, Last updated: 28/04/2021 -
List item
Orphan designation: Cannabidiol for: Treatment of tuberous sclerosis (updated)
Date of first decision: 17/01/2018, Positive, Last updated: 26/04/2021 -
List item
Orphan designation: Diclofenamide for: Treatment of periodic paralysis (updated)
Date of first decision: 17/02/2016, Positive, Last updated: 26/04/2021 -
List item
Orphan designation: (3'R,4'S,5'R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide mono(4-methylbenzenesulfonate) monohydrate for: Treatment of soft tissue sarcoma (updated)
Date of first decision: 20/03/2017, Positive, Last updated: 22/04/2021 -
List item
Orphan designation: Eicosapentaenoic acid for: Treatment of familial adenomatous polyposis (FAP) (updated)
Date of first decision: 08/10/2009, Positive, Last updated: 22/04/2021 -
List item
Orphan designation: Somapacitan for: Treatment of growth hormone deficiency
Date of first decision: 24/08/2018, Positive, Last updated: 15/04/2021 -
List item
Orphan designation: Ribavirin for: Treatment of Lassa fever
Date of first decision: 21/02/2018, Positive, Last updated: 12/04/2021 -
List item
Orphan designation: Ribavirin for: Treatment of Crimean-Congo haemorrhagic fever
Date of first decision: 21/03/2018, Positive, Last updated: 12/04/2021 -
List item
Orphan designation: Adeno-associated viral vector serotype 9 containing the human cardiac calsequestrin gene for: Treatment of catecholaminergic polymorphic ventricular tachycardia
Date of first decision: 29/07/2014, Positive, Last updated: 09/04/2021 -
List item
Orphan designation: Radio-iodinated (131I) anti-CD45 murine monoclonal antibody for: Treatment in haematopoietic stem cell transplantation
Date of first decision: 14/10/2016, Positive, Last updated: 09/04/2021 -
List item
Orphan designation: Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus for: Treatment in haematopoietic stem cell transplantation
Date of first decision: 24/03/2020, Positive, Last updated: 07/04/2021 -
List item
Orphan designation: Synthetic 12 amino acid peptide designed after subcommissural organ-spondin for: Treatment of spinal cord injury
Date of first decision: 13/11/2013, Positive, Last updated: 07/04/2021 -
List item
Orphan designation: Adeno-associated virus serotype 9 containing the human ASPA gene for: Treatment of Canavan disease
Date of first decision: 04/06/2020, Positive, Last updated: 06/04/2021 -
List item
Orphan designation: tripotassium citrate monohydrate, Potassium hydrogen carbonate for: Treatment of cystinuria
Date of first decision: 09/01/2020, Positive, Last updated: 06/04/2021 -
List item
Orphan designation: Sparsentan for: Treatment of primary IgA nephropathy
Date of first decision: 19/10/2020, Positive, Last updated: 24/03/2021 -
List item
Orphan designation: 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide for: Treatment of focal segmental glomerulosclerosis
Date of first decision: 11/11/2015, Positive, Last updated: 24/03/2021